For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 24-30, 2026
FDA and innovation FDA and CMS move on personalized gene therapies. The FDA released draft guidance that lets developers of…
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Search Posts
American Chemistry
IRIS: Bad Science, Real World Consequences
American Chemistry cited CEI’s publication by Senior Fellow Angela Logomasini on the IRIS. In February 2019 the Competitive Enterprise Institute (CEI) provided some important…
Comment
CEI Comments to FDA on Modifications to Compliance Policy for Certain Deemed Tobacco Products
Dear Dr. Gottlieb: The Competitive Enterprise Institute (CEI) welcomes the opportunity to offer the following comments on the Food and Drug Administration’s (FDA) proposed modifications…
Real Clear Policy
Federal Pot Prohibition Nears its End
America has made up its mind on marijuana. Most Americans think it should be legal, and all but two states have decriminalized or legalized the drug in…
News Release
CEI Report Calls for Elimination of EPA’s Flawed Integrated Risk Information System
A new report released today by the Competitive Enterprise Institute (CEI) shows EPA’s Integrated Risk Information System (IRIS) has significant problems with methodology, relies on…
Study
EPA’s Flawed IRIS Program Is Far from Gold Standard
Environmental activists claim that the U.S. Environmental Protection Agency’s Integrated Risk Information System (IRIS) represents the gold standard for risk assessment.[i] In…
Products
Free to Prosper: Food, Drugs, and Consumer Freedom
View the full chapter on food, drugs, and consumer freedom here Few matters are as important to consumers as the foods they eat, the…